Investment Club Stock Analysis

Intuitive Surgical Inc (ISRG)

Intuitive Surgical Inc (ISRG)

$542.32 (-0.92%)

Company Profile
Country
US
IPO Date
2000-06-13
Market Cap
$192,250
Industry
Health Care
Price Data
High
$548.99
Low
$537.69
Open
$546.00
Previous Close
$547.36
Last Updated
2025-12-12 21:00:00
Analyst Recommendations
PeriodStrong BuyBuyHoldSellStrong Sell
2025-12-0111 1513 10
2025-11-0112 1513 10
2025-10-0112 1512 10
2025-09-0112 1512 10
Balance Sheet
Cash and cash equivalents: $2,027,400,000
Short-term investments: $1,985,900,000
Accounts receivable, net of allowances of $30.7 and $27.1 as of December 31, 2024, and 2023, respectively: $1,225,400,000
Inventory: $1,487,200,000
Prepaids and other current assets: $385,100,000
Total current assets: $7,111,000,000
Property, plant, and equipment, net: $4,646,600,000
Long-term investments: $4,819,100,000
Deferred tax assets: $1,045,100,000
Intangible and other assets, net: $773,900,000
Goodwill: $347,500,000
Total assets: $18,743,200,000
Accounts payable: $193,400,000
Accrued compensation and employee benefits: $535,600,000
Deferred revenue: $468,800,000
Other accrued liabilities: $547,500,000
Total current liabilities: $1,745,300,000
Other long-term liabilities: $468,300,000
Total liabilities: $2,213,600,000
Preferred stock, 2.5 shares authorized, $0.001 par value, issuable in series; zero shares issued and outstanding as of December 31, 2024, and 2023: $0
Common stock, 600.0 shares authorized, $0.001 par value, 356.6 shares and 352.3 shares issued and outstanding as of December 31, 2024, and 2023, respectively: $400,000
Additional paid-in capital: $9,681,300,000
Retained earnings: $6,803,300,000
Accumulated other comprehensive loss: $-51,300,000
Total Intuitive Surgical, Inc. stockholders’ equity: $16,433,700,000
Noncontrolling interest in joint venture: $95,900,000
Total stockholders’ equity: $16,529,600,000
Total liabilities and stockholders’ equity: $18,743,200,000
Cash Flow
Net income: $2,337,500,000
Depreciation and loss on disposal of property, plant, and equipment, net: $445,300,000
Amortization of intangible assets: $16,700,000
Gain on sale of business: $1,100,000
(Gain) loss on investments and (accretion) amortization of investment discounts and premiums, net: $43,300,000
Deferred income taxes: $135,300,000
Share-based compensation expense: $676,800,000
Amortization of contract acquisition assets: $37,700,000
Accounts receivable: $95,900,000
Inventory: $830,000,000
Prepaids and other assets: $231,800,000
Accounts payable: $-400,000
Accrued compensation and employee benefits: $99,300,000
Deferred revenue: $31,200,000
Other liabilities: $108,300,000
Net cash provided by operating activities: $2,415,000,000
Purchases of investments: $5,139,600,000
Proceeds from sales of investments: $100,200,000
Proceeds from maturities of investments: $2,878,800,000
Purchase of property, plant, and equipment: $1,111,200,000
Acquisition of businesses, net of cash, and intellectual property and other investing activities: $1,000,000
Net cash provided by (used in) investing activities: $-3,272,800,000
Proceeds from issuance of common stock relating to employee stock plans: $429,400,000
Taxes paid related to net share settlement of equity awards: $270,000,000
Repurchase of common stock: $0
Cash dividends paid by joint venture to noncontrolling interest: $8,000,000
Payment of deferred purchase consideration: $500,000
Net cash provided by (used in) financing activities: $150,900,000
Effect of exchange rate changes on cash, cash equivalents, and restricted cash: $-800,000
Net increase (decrease) in cash, cash equivalents, and restricted cash: $-707,700,000
Income Statement
Total revenue: $8,352,100,000
Total cost of revenue: $2,717,900,000
Gross profit: $5,634,200,000
Selling, general and administrative: $2,140,000,000
Research and development: $1,145,300,000
Total operating expenses: $3,285,300,000
Income from operations: $2,348,900,000
Interest and other income, net: $324,900,000
Income before taxes: $2,673,800,000
Income tax expense: $336,300,000
Net income: $2,337,500,000
Less: net income attributable to noncontrolling interest in joint venture: $14,900,000
Net income attributable to Intuitive Surgical, Inc.: $2,322,600,000
Basic (usd per share): $7
Diluted (usd per share): $6
Basic (shares): $355,200,000
Diluted (shares): $362,000,000
Change in foreign currency translation gains (losses): $-53,200,000
Change in unrealized gains (losses): $15,000,000
Less: Reclassification adjustment for (gains) losses on securities: $-100,000
Net change: $15,100,000
Change in unrealized gains (losses): $5,700,000
Less: Reclassification adjustment for losses on hedge instruments: $-7,800,000
Net change: $13,500,000
Change in unrealized gains (losses): $14,900,000
Less: Reclassification adjustment for (gains) losses on employee benefit plans: $300,000
Net change: $15,200,000
Other comprehensive income (loss), net of tax: $-39,800,000
Total comprehensive income: $2,297,700,000
Less: comprehensive income attributable to noncontrolling interest: $14,200,000
Total comprehensive income attributable to Intuitive Surgical, Inc.: $2,283,500,000
Latest News